Transcriptomic analysis of the effects of a single dose of ibogaine: Uncovering potential therapeutic pathways in miceJudit Biosca-Brull, Genis Ona, Lineth Alarcón-Franco et al.
The FDA's psychedelic sea-change: what accelerated clinical trials for psilocybin, methylone, and ibogaine mean for mental health and neuroscience research | Boris HeifetsFrom Our Neurons to Yours